Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

This study has been completed.
Vion Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: August 27, 2007
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)